Andersson's arctic moss vs

Arctoa anderssonii compared with Clitopilus passeckerianus

Key Differences

Andersson's arctic moss is Endangered while is Not Evaluated.

Taxonomic Classification

Rank	Andersson's arctic moss
Kingdom	Plantae (Plants)	Fungi (Fungi)
Phylum	Bryophyta	Basidiomycota (Club Fungi)
Class	Bryopsida (Bryopsida)	Agaricomycetes (Mushrooms)
Order	Dicranales (Dicranales)	Agaricales (Gilled Mushrooms)
Family	Rhabdoweisiaceae	Entolomataceae
Genus	Arctoa	Clitopilus
Species	Arctoa anderssonii	Clitopilus passeckerianus

Conservation Status

Andersson's arctic moss

EN — Endangered

NE — Not Evaluated

Physical Characteristics

Attribute	Andersson's arctic moss
Diet	—	—
Average Lifespan	—	—
Average Length	—	—
Average Weight	—	—

Habitat & Geographic Range

Andersson's arctic moss

Habitat

Native to Europe, inhabiting ecosystems characteristic of the region.

Range

Distributed across Norway and Sweden. Currently classified as Endangered on the IUCN Red List, this species faces significant conservation challenges across its range.

Habitat

Typically found in forest floors, decomposing wood, and soil ecosystems.

Range

Distributed across Norway and Sweden.

Andersson's arctic moss

The Andersson's arctic moss (Arctoa anderssonii) is a species in the genus Arctoa. It is currently classified as Endangered on the IUCN Red List. Native to Europe, inhabiting ecosystems characteristic of the region.

Clitopilus passeckerianus is a white-rot agaric fungus in the family Entolomataceae notable for its role as a natural producer of pleuromutilin, a diterpenoid antibiotic compound that serves as the biosynthetic precursor for the veterinary and human antibiotic drugs tiamulin and valnemulin, used to treat Mycoplasma infections in livestock. First described from European woodland habitats, the species produces the characteristic Clitopilus fruiting body: a pale, whitish cap with decurrent, crowded gills becoming pinkish at maturity from angular spores, and a farinaceous odor. Its antibiotic-producing capacity makes C. passeckerianus of significant pharmaceutical interest, and biosynthetic studies of pleuromutilin production have informed synthetic chemistry approaches to antibiotic development. The species inhabits temperate deciduous woodland floors in Europe, fruiting in autumn among leaf litter. Discovery of its pleuromutilin biosynthetic pathway has opened avenues for heterologous expression and semi-synthetic modification aimed at developing novel antibiotics to counter antibiotic-resistant bacterial pathogens.